AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 19 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $6,032,000 | -54.6% | 9,000,000 | -45.8% | 3.47% | -53.6% |
Q1 2017 | $13,280,000 | -23.0% | 16,600,000 | -31.4% | 7.48% | -27.1% |
Q4 2016 | $17,243,000 | +8.1% | 24,200,000 | 0.0% | 10.27% | -21.1% |
Q3 2016 | $15,957,000 | +61.8% | 24,200,000 | +39.9% | 13.01% | +28.7% |
Q2 2016 | $9,861,000 | – | 17,300,000 | – | 10.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 9,000,000 | $6,728,000 | 2.88% |
Context Capital Management, LLC | 1,250,000 | $941,000 | 1.71% |
Tekla Capital Management LLC | 13,000,000 | $36,801,000 | 1.32% |
WOLVERINE ASSET MANAGEMENT LLC | 32,934,000 | $24,701,000 | 0.58% |
ZAZOVE ASSOCIATES LLC | 16,360,000 | $12,321,000 | 0.57% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 42,500,000 | $31,769,000 | 0.49% |
FALCON POINT CAPITAL, LLC | 1,500,000 | $1,121,000 | 0.40% |
Amici Capital, LLC | 10,000,000 | $7,525,000 | 0.36% |
Castle Creek Arbitrage, LLC | 4,000,000 | $3,037,000 | 0.24% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 15,000,000 | $11,556,000,000 | 0.24% |